Vanderbilt has received an NIH grant to launch the Vanderbilt Antibody and Antigen Discovery for Clostridioides difficile Vaccines, or VANDy-CdV.
Vanderbilt’s James Crowe Jr., MD, Paul Harris, PhD, and Jamey Young, PhD, have been elected to the 2023 College of Fellows of the American Institute for Medical and Biological Engineering (AIMBE).